TrovaGene, Inc. is registered as a diagnostic company that promotes better patient outcome, especially for those that are afflicted with the Big C. As a diagnostic company, it focuses on the diagnosis and monitoring of cancer.
The company continues to defy the science of imaging and biopsy. It intends to provide physicians with the diagnostic system that would allow them to fully assist the treatment process of patients with cancer. The offerings of the company are categorized as noninvasive and are used to monitor before, during and after treatment of cancer. By providing these options, they are mitigating the pain, costs and risks that cancer patients have to face to combat the disease.
The lead product of the company is a urine-based cell-free molecular diagnostic technology. TroveGene, Inc. is strongly positioned to create joint ventures with other companies to penetrate other medical disciplines, including in areas such as transplant medicine, infectious diseases and prenatal diseases.
No comments:
Post a Comment